Sana Pharma Medical

What Sana Pharma Medical does

Sana Pharma Medical AS is a privately held Norwegian pharmaceutical company headquartered in Lysaker (Oslo), founded in 2014, operating exclusively in Norway with a headcount in the 11–50 range. The company specialises in over-the-counter (OTC) plant-based medicines and dietary supplements organised around four therapeutic areas: sleep and anxiety (Sedix, Lunixen, three Melatonin formats and Duranoct), cardiovascular and circulation (Solvenix for chronic venous insufficiency, Senikol for cholesterol), musculoskeletal and migraine (Giduxa for joint pain, Glitinum for migraine prevention), and women's health (Remifemin for menopausal symptoms, Remisoft for vaginal dryness). The underlying technology centres on traditional herbal extracts — including Harpagophytum procumbens, Tanacetum parthenium, Aesculus hippocastanum, Passiflora incarnata, Valeriana officinalis and Cimicifuga racemosa — with proprietary dosage-form technology on the Duranoct tri-layer extended-release tablet that combines melatonin with valerian, passion flower, hawthorn, lemon balm and vitamin B6.

The company generates revenue through one-time OTC unit sales of branded plant-based medicines and dietary supplements, distributed exclusively through Norwegian pharmacy chains (Vitus Apotek, Apotek 1, Boots Apotek, independents) and licensed online pharmacies. Sana Pharma Medical does not publish pricing and does not operate outside Norway; it also leverages external manufacturing and distribution partnerships — etol Gesundheitspflege und Pharmaprodukte GmbH produces Remisoft, and Schaper & Brümmer handles Remifemin and Remisoft distribution in Norway — making the operating model asset-light. The customer base is fragmented end-consumers purchasing OTC products at pharmacies, supplemented by a dedicated healthcare-professional portal supplying product training, clinical materials and downloadable resources to doctors and pharmacists across Norway. The company holds category-exclusive OTC positioning in Norway for Glitinum (the only prescription-free migraine preventive) and Remifemin (the only estrogen-free OTC treatment for menopausal hot flashes), and has shipped three product launches over 2022–2024 (Solvenix, Glitinum, Giduxa).

Name

Sana Pharma Medical

Legal name

Sana Pharma Medical AS

Website

https://sanapharma.no

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Sana Pharma Medical AS is a privately held Norwegian pharmaceutical company that markets prescription-free plant-based medicines and dietary supplements through Norwegian pharmacies, addressing sleep disorders, anxiety, migraine, circulation, cholesterol, joint pain, and women's health. Revenue is generated via OTC unit sales, with Glitinum and Remifemin holding category-exclusive OTC positions in Norway.

Ownership category

akta.pro rank

Product category

OTC Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• OTC pharmaceuticals
• Herbal medicines
• Dietary supplements
• Sleep aids
• Plant-based medicines

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel

Revenue model

1. Over-the-Counter Pharmaceutical Products: Sana Pharma Medical generates revenue through the sale of OTC pharmaceutical products, including prescription-free medicines and dietary supplements, distributed exclusively through pharmacies and online pharmacy channels in Norway.
2. Plant-Based Medicines: Revenue from plant-based pharmaceutical products classified as either established herbal medicinal products (veletablert) or traditional herbal medicinal products (tradisjonell), sold through pharmacy distribution channels.
3. Melatonin Dietary Supplements: Revenue from melatonin-based dietary supplements (costtilskudd) sold OTC in pharmacies without prescription requirement, including standard, extended-release, and spray formulations.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Sana Pharma Medical is a Norwegian pharmaceutical company that develops and markets a portfolio of over-the-counter (OTC) plant-based medicines and dietary supplements, including products for sleep, nasal congestion, and male sexual health. The company distributes its products through Norwegian pharmacies, health food stores, and online pharmacies, targeting adult consumers seeking self-care alternatives.

Product overview

Sana Pharma Medical is a Norwegian pharmaceutical company operating in the over-the-counter (OTC) medicines and dietary supplements market. The company's product portfolio consists of prescription-free (OTC) plant-based medicinal products and dietary supplements organized around four therapeutic areas: (1) Sleep and anxiety — Sedix® (passionflower, traditional plant-based), Lunixen® (valerian, well-established plant-based), Melatonin product line (Melatonin 1mg capsules, Melatonin Natt depot tablets, Melatonin Spray, Melatonin Duranoct® combination supplement); (2) Cardiovascular/circulatory — Solvenix® (horse chestnut for chronic venous insufficiency) and Senikol® (plant sterols for cholesterol); (3) Pain/musculoskeletal — Giduxa® (devil's claw for joint pain, new 2024 launch) and Glitinum® (feverfew for migraine prevention, 2023 launch); (4) Women's health — Remifemin® (black cohosh for menopausal symptoms) and Remisoft® (vaginal moisturizing cream for vaginal dryness). The portfolio spans traditional and well-established plant-based medicinal products, dietary supplements, and a medical device. All products are sold through pharmacies (Apotek 1, Boots, Vitus, Farmasiet) and online pharmacies in Norway.

Differentiator

Problem solved

Functional benefit

Brands

• Giduxa: Non-prescription medicine against joint pain (osteoarthritis, rheumatoid arthritis, rheumatism) containing extract of devil's claw.
• Senikol
• Glitinum
• Solvenix
• Sedix
• Lunixen
• Duranoct
• Melatonin 1mg
• Melatonin Natt
• Melatonin Spray
• Remifemin
• Remisoft

Products and services

• Lunixen OTC sleep aid tablet combining valerian, lemon balm, and melatonin in a three-layer tablet with both immediate and prolonged release, designed for adults experiencing occasional sleeplessness.
• Sinux

Quantifiable outcome

• Sleep problems affect approximately 1 in 3 Norwegian adults weekly, representing approximately 1.4 million people
• +8 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered minor.

• etol Gesundheitspflege- und Pharmaprodukte GmbHminorOEM/ Whitelabel/ Licensing PartnerGerman manufacturer producing Remisoft vaginal cream for Sana Pharma Medical. etol manufactures the product at their facility in Oberkirch, Germany (Konrad-Adenauer-Straße 3, 77704 Oberkirch). Sana Pharma Medical handles sales and distribution in Norway.
• Schaper & Brümmer GmbH & Co. KGminorChannel Partner/ Reseller/ DistributorGerman pharmaceutical company (Bahnhofstraße 35, 38259 Salzgitter, Germany) responsible for sales and distribution of Remisoft in the Norwegian market under Sana Pharma Medical. Also distributes Remifemin product in the Norwegian market.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Midsona AB: Swedish natural and health products company distributing herbal/natural remedies and supplements through Nordic pharmacy and health retail channels. Directly comparable as a Nordic-focused phytopharmaceutical and dietary supplement brand operator with similar product positioning.
• Orkla Health: Norwegian/Nordic consumer health division of Orkla, distributing OTC health products including herbal and natural remedies (e.g., Jordan, Möller's, SanaSol) through Nordic pharmacies and retail. Comparable as a Nordic-focused branded OTC health products company with similar distribution model.
• Schaper & Brümmer GmbH & Co. KG: German pharmaceutical company specializing in plant-based medicines (Remifemin, etc.) that also distributes products through Sana Pharma Medical in Norway. Directly comparable as a developer and manufacturer of phytopharmaceutical products in the same therapeutic areas.
• Aboca S.p.A. Italian pharmaceutical company focused entirely on plant-based medicinal products and natural supplements distributed through European pharmacy channels. Closely comparable business model combining herbal pharmaceuticals with dietary supplements via pharmacy distribution.
• A. Vogel AG: Swiss manufacturer of plant-based medicines and natural remedies (e.g., A.Vogel products for sleep, menopause, joint pain) sold through European pharmacies. Highly comparable as a phytopharmaceutical brand portfolio operator targeting similar self-medication use cases.

Emerging players

• BioGaia AB: Swedish probiotic and health company selling branded consumer health products through pharmacies in multiple markets. Comparable as a Nordic-based science-backed health brand sold via pharmacy channels, though focused on probiotics rather than herbal medicines.

Broad incumbents

• Perrigo Company plc: Large global OTC pharmaceutical company with broad presence in European pharmacy channels including store-brand and branded self-care products. Comparable as a competing OTC supplier to Norwegian pharmacies across multiple therapeutic categories.
• Haleon plc: Global consumer healthcare company (formerly GSK Consumer) with major OTC brands in sleep, pain, and oral health sold through European pharmacies. Comparable as a multinational competitor occupying shelf space in Norwegian pharmacies against Sana Pharma products.
• Sanofi Consumer Healthcare: Global pharmaceutical company with a major consumer health division covering OTC sleep, pain, allergy, and digestive products sold through pharmacies worldwide. Comparable as a large incumbent competitor across multiple of Sana Pharma's therapeutic categories.
• Takeda (Nycomed legacy): Takeda acquired Norway-headquartered Nycomed and maintains significant Nordic OTC and prescription pharmaceutical operations including consumer health brands. Comparable as a large pharmaceutical incumbent with established Norwegian/Nordic pharmacy distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks1 record

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sana-pharma-medical
• Facebookfacebook.com/sanapharmamedical

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sana Pharma Medical